首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1624396

全球細胞分選市場規模（依產品/服務、技術、最終用戶、地區、範圍和預測）

Global Cell Sorting Market Size By Product and Services, By Technology, By End- Users, By Geographic Scope and Forecast

出版日期: 2024年11月13日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

細胞分選市場規模及預測

2023 年細胞分選市場規模價值為 2.5983 億美元，預計到 2031 年將達到 4.4013 億美元，2024 年至 2031 年的複合年增長率為 6.81%。細胞分選是一種複雜的實驗室技術，用於根據細胞的物理和生化特性從混合群體中分離和隔離特定細胞類型。此方法對於生物研究、臨床診斷和藥物開發等多種應用至關重要。這對於各種應用都很重要，並將極大地推動研究和治療。在基礎研究中，細胞分選用於從異質材料中分離特定的細胞群，使科學家能夠深入研究細胞機制、基因表現和細胞活動。

細胞分選技術預計將在個人化醫療和治療技術的改進中發揮越來越重要的作用。隨著微流體技術和自動化技術的進步，未來的細胞分選器可能會提供更高的解析度、更快的處理速度和更高的準確性。這將改進單細胞分析等領域的技術，瞭解單一細胞的異質性可以實現更有效和個人化的治療。

全球細胞分選市場動態

影響全球細胞分選市場的關鍵市場動態是：

主要市場驅動因子

生物技術與基因體學的進展

生物技術和基因組學的快速進步是細胞分選市場的主要驅動力。單細胞基因組學和蛋白質組學是需要精確分離細胞以評估單一細胞水平的基因表現、基因突變和蛋白質相互作用的技術。

越來越重視個人化醫療

對個人化醫療和客製化治療的日益關注對細胞分選業務產生了重大影響。精準醫療是基於瞭解每位患者的基因和分子特徵，以便更好地實施個人化治療。

癌症研究和免疫療法的興起

對癌症研究和免疫療法日益關注的是主要的市場驅動力。癌症研究計畫的不斷擴大以及以免疫療法和細胞療法為重點的臨床試驗的增加，對可以支持這些複雜、高通量應用的細胞分選技術產生了強烈的需求。

主要問題

樣品製備與品質：

成功的細胞分選依賴高品質的樣品製備。樣品準備不當可能會促使分類錯誤並影響結果。細胞團塊、碎片和不一致的樣本量都會影響分選過程的效率和準確性。保持一致、高品質的樣品製備是一項具有課題性的任務。

資料管理與分析：

細胞分選會產生大量必須處理和檢查的資料。這不僅需要篩選數據，還需要解釋所獲得的生物數據並得出適當的結論。處理和分析此類數據可能具有課題性，需要先進的軟體和處理資源。

生物技術與基因體學的進展：

生物技術和遺傳學的快速進展是細胞分選市場的主要驅動力。研究和臨床環境中對精確細胞分析和分離的需求日益增加，推動了對複雜細胞分選技術的需求。單細胞基因組學和轉錄組學等技術需要高解析度細胞分選來提供有關細胞活動和多樣性的詳細見解。

主要趨勢：

細胞分選技術的進步：

細胞分選技術的創新正在推動市場向前發展。現代細胞分選器現在提供高速分選、提高靈敏度和多參數分析等先進功能。基於微流體的分選器和數位液滴分選正在改變這一領域，因為它們能夠更精確、更有效地分離複雜的細胞群。

個人化醫療需求不斷成長：

個人化醫療的發展對細胞分選市場產生了重大影響。細胞分選對於個人化治療的發展至關重要，包括在細胞層面上發現生物標記和闡明疾病機制。

幹細胞研究中的應用日益增多

幹細胞研究是細胞分選市場成長的主要驅動力。精確選擇和純化幹細胞的能力對於理解幹細胞生物學和開發基於幹細胞的療法至關重要。隨著再生醫學的進步，用於分離和表徵幹細胞的先進細胞分選技術變得越來越重要。

Becton, Dickinson and Company
Beckman Coulter, Inc.（A Subsidiary of Danaher Corporation）
Bio-Rad Laboratories, Inc.
Sony Biotechnology Inc.（A Wholly Owned Subsidiary of Sony Corporation of America）
MiltenyiBiotec GmbH
Affymetrix, Inc.（A Thermo Fisher Scientific Company）
SysmexPartec GmbH（A Subsidiary of Sysmex Corporation）
On-Chip Biotechnologies Co., Ltd.
Cytonome/St, LLC
Union Biometrica, Inc

第 11 章重大進展

產品發佈/開發
合併和收購
業務擴展
夥伴關係和合作關係

第 12 章附錄

相關研究

簡介目錄

Product Code: 24157

Cell Sorting Market Size And Forecast

Cell Sorting Market Size was valued at USD 259.83 Million in 2023 and is projected to reach USD 440.13 Million by 2031, growing at a CAGR of 6.81% from 2024 to 2031. Cell sorting is a complex laboratory technique that separates and isolates specific types of cells from a mixed population depending on their physical and biochemical properties. This method is critical for a variety of applications including biological research, clinical diagnostics, and pharmaceutical development. It is critical in a variety of applications, greatly advancing research and therapeutic practices. In fundamental research, cell sorting is used to isolate certain cell populations from heterogeneous materials allowing scientists to explore cellular mechanisms, gene expression, and cell activity in depth.

Cell sorting technology is projected to play an increasingly important role in personalized medicine and enhanced therapeutic techniques. Future cell sorters will provide higher resolution, faster processing rates, and greater precision as microfluidics and automation progress. This will improve skills in areas like single-cell analysis where knowing the heterogeneity of individual cells can lead to more effective and personalized treatments.

Global Cell Sorting Market Dynamics

The key market dynamics that are shaping the global Cell Sorting Market include:

Key Market Drivers:

Advances in Biotechnology and Genomics

: The rapid advancement of biotechnology and genomics is a major driver of the Cell Sorting Market. Single-cell genomics and proteomics are techniques that need exact cell separation to evaluate gene expression, genetic variants, and protein interactions at the individual cell level.

Growing Focus on Personalized Medicine:

The growing focus on personalized medicine and tailored therapeutics is having a substantial impact on the cell sorting business. Personalized medicine is based on understanding individual patients' genetic and molecular profiles to better personalize treatments.

Increase in Cancer Research and Immunotherapy

: Increased emphasis on cancer research and immunotherapy is a major market driver. The expansion of cancer research programs as well as the increasing number of clinical trials focusing on immunotherapy and cell-based treatments creates a strong demand for cell-sorting technologies capable of supporting these complicated and high-throughput applications.

Key Challenges:

Sample Preparation and Quality:

Successful cell sorting is dependent on high-quality sample preparation. Poorly prepared samples can result in incorrect sorting and compromised results. Cell aggregation, debris, and sample volume discrepancies can all have an impact on how efficiently and accurately the sorting process works. Maintaining consistent and high-quality sample preparation is a considerable task.

Data Management and Analysis:

Cell sorting generates large volumes of data that must be handled and examined. This requires not only sorting data but also interpreting the ensuing biological data to draw relevant conclusions. Handling and analyzing this data can be difficult necessitating advanced software and processing resources.

Advancements in Biotechnology and Genomics:

Rapid advances in biotechnology and genetics are a key driver of the Cell Sorting Market. The growing requirement for precise cell analysis and separation in research and clinical settings is driving up demand for sophisticated cell sorting technologies. Techniques such as single-cell genomics and transcriptomics necessitate high-resolution cell sorting to provide detailed insights into cellular activities and diversity.

Key Trends:

Cell Sorter Technology Advancements:

Innovations in cell sorter technology are propelling the market forward. Modern cell sorters now have advanced features such as high-speed sorting, increased sensitivity, and multi-parameter analysis. Microfluidic-based sorters and digital droplet sorting are transforming the discipline by enabling more precise and efficient separation of complicated cell populations.

Increased Demand for Personalized Medicine:

The push for personalized medicine has a substantial impact on the Cell Sorting Market. Cell sorting is critical for finding biomarkers and understanding disease mechanisms at the cellular level both of which are necessary for the development of customized therapeutics.

Rising Applications in Stem Cell Research

: Stem cell research is a significant driver of growth in the Cell Sorting Market. The ability to accurately sort and purify stem cells is essential for understanding their biology and creating stem cell-based therapeutics. As regenerative medicine improves, sophisticated cell sorting technologies to isolate and evaluate stem cells become increasingly important.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Cell Sorting Market Regional Analysis

Here is a more detailed regional analysis of the global Cell Sorting Market:

North America:

The North American region dominates the global Cell Sorting Market owing mostly to significant investments in R&D and a strong healthcare infrastructure. This dominance is strengthened by the presence of large industry companies and sophisticated technological skills in the region. Significant funding for life sciences research is a key driver of the North American Cell Sorting Market.

According to the National Institutes of Health (NIH), the world's largest public supporter of biomedical research, the budget for fiscal year 2023 is USD 47.5 Billion, up USD 2.5 Billion from 2022. This large grant directly supports research initiatives that use cell sorting methods. The California Institute for Regenerative Medicine (CIRM), the largest state-funded stem cell organization in the United States, has provided over USD 2.9 Billion in grants since its founding, promoting research that mainly relies on cell sorting technology.

Furthermore, the Alliance for Regenerative Medicine reports that as of 2021, there were over 1,085 regenerative medicine enterprises worldwide, with a sizable proportion situated in North America. This concentration of research and development activities in regenerative medicine and stem cell therapies drives demand for improved cell sorting solutions in the region cementing North America's dominance in the worldwide Cell Sorting Market.

Asia Pacific:

The Asia Pacific region is having the highest growth in the Cell Sorting Market owing mostly to rapid advances in biotechnology and increased spending in healthcare research & development. Countries such as China, Japan, and India have exceptionally rapid growth. The rising frequency of chronic diseases as well as the resulting demand for enhanced diagnosis and treatment approaches are significant drivers of the Cell Sorting Market in Asia Pacific.

According to the World Health Organization (WHO), noncommunicable illnesses cause 71% of all deaths worldwide with Asia Pacific countries bearing a disproportionate burden. According to China's National Cancer Center, 10.7 million new cancer cases were reported in 2020. This high illness burden is driving investments in cell-based research and therapeutics resulting in increased demand for cell-sorting technology.

Global Cell Sorting Market: Segmentation Analysis

The Global Cell Sorting Market is segmented based on Product and Services, Technology, End-Users, and Geography.

Cell Sorting Market, By Product and Services

Cell Sorting Reagents and Consumables
Cell Sorting Services
Cell Sorters

Based on Products and Services, the Global Cell Sorting Market is bifurcated into Cell Sorting Reagents and Consumables, Cell Sorting Services, and Cell Sorters. In the global Cell Sorting Market, cell sorters are the dominant product and service segment. This dominance is due to the essential role cell sorters play in enabling researchers and clinicians to separate and analyze specific cell populations with high precision. Advances in technology have led to the development of more sophisticated cell sorters offering improved accuracy, speed, and functionality which are critical for applications in research, diagnostics, and therapeutic development.

Cell Sorting Market, By Technology

Fluorescence-Based Droplet Cell Sorting
Jet-In-Air Cell Sorting
Cuvette-Based Cell Sorting
Magnetic-Activated Cell Sorting (MACS)
Micro-Electromechanical Systems (MEMS) - Microfluidics

Based on Technology, the Global Cell Sorting Market is bifurcated into Fluorescence-Based Droplet Cell Sorting, Jet-In-Air Cell Sorting, Cuvette-Based Cell Sorting, Magnetic-Activated Cell Sorting (MACS), and Micro-Electromechanical Systems (MEMS) - Microfluidics. In the global Cell Sorting Market, fluorescence-based droplet cell sorting is the dominant technology. This dominance is attributed to its high efficiency and precision in separating cells based on fluorescence markers. Fluorescence-based systems can analyze multiple parameters simultaneously allowing for detailed cell characterization and sorting with high purity. This technology is widely used in research, clinical diagnostics, and drug development due to its ability to handle complex samples and provide high-resolution results.

Cell Sorting Market, By End-Users

Research Institutions
Medical Schools and Academic Institutions
Pharmaceutical and Biotechnology Companies
Hospitals and Clinical Testing Laboratories

Based on End-Users, the Global Cell Sorting Market is bifurcated into Research Institutions, Medical Schools and Academic Institutions, Pharmaceutical and Biotechnology Companies, and Hospitals and Clinical Testing Laboratories. Pharmaceutical and biotechnology companies are the dominant end-users in the global Cell Sorting Market. This dominance stems from the crucial role cell sorting plays in drug development, personalized medicine, and cellular therapies. These companies utilize cell sorting technology to isolate and analyze specific cell populations which is essential for developing targeted therapies and understanding disease mechanisms.

Cell Sorting Market, By Geography

North America
Europe
Asia Pacific
Middle East and Africa
Rest of the World

Based on Geography, the Global Cell Sorting Market is classified into North America, Europe, Asia Pacific, Middle East and Africa, and the Rest of the World. North America is the dominant region in the global Cell Sorting Market. This dominance is attributed to the region's advanced healthcare infrastructure, significant investment in research and development, and high adoption rates of cutting-edge technologies. North America, particularly the United States, hosts numerous leading biotechnology firms, academic institutions, and research organizations that drive demand for advanced cell sorting technologies.

Key Players

The "Global Cell Sorting Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
Becton, Dickinson and Company, Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation), Bio-Rad Laboratories, Inc., Sony Biotechnology, Inc. (A Wholly Owned Subsidiary of Sony Corporation of America), MiltenyiBiotec GmbH, Affymetrix, Inc. (A Thermo Fisher Scientific Company), SysmexPartec GmbH (A Subsidiary of Sysmex Corporation), On-Chip Biotechnologies Co., Ltd., Cytonome/St, LLC, Union Biometrica, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Cell Sorting Market Key Developments

In May 2023, BD, a medical technology company, introduced new cell sorting equipment with two revolutionary technologies. This allows scientists to find comprehensive information about cells that were previously invisible in typical flow cytometry research.
In January 2023, Thermo Fisher Scientific announced that the Bigfoot Spectral Cell Sorter would be available in India. The first-of-its-kind cell sorting Technology combines traditional sorting with spectral sorting and analysis to give simple, high-speed cell sorting.

1 INTRODUCTION OF GLOBAL CELL SORTING MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL CELL SORTING MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL CELL SORTING MARKET, BY PRODUCT AND SERVICES

5.1 Overview
5.2 Cell Sorting Reagents and Consumables
5.3 Cell Sorting Services
5.4 Cell Sorters

6 GLOBAL CELL SORTING MARKET, BY TECHNOLOGY

6.1 Overview
6.2 Fluorescence-Based Droplet Cell Sorting
6.3 Jet-In-Air Cell Sorting
6.4 Cuvette-Based Cell Sorting
6.5 Magnetic-Activated Cell Sorting (MACS)
6.6 Micro-Electromechanical Systems (MEMS) - Microfluidics

7 GLOBAL CELL SORTING MARKET, BY END USER

7.1 Overview
7.2 Research Institutions
7.3 Medical Schools and Academic Institutions
7.4 Pharmaceutical and Biotechnology Companies
7.5 Hospitals and Clinical Testing Laboratories

8.GLOBAL CELL SORTING MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9 GLOBAL CELL SORTING MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Becton, Dickinson and Company
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Bio-Rad Laboratories, Inc.
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Sony Biotechnology Inc. (A Wholly Owned Subsidiary of Sony Corporation of America)
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 MiltenyiBiotec GmbH
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Affymetrix, Inc. (A Thermo Fisher Scientific Company)
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 SysmexPartec GmbH (A Subsidiary of Sysmex Corporation)
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 On-Chip Biotechnologies Co., Ltd.
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Cytonome/St, LLC
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Union Biometrica, Inc
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments